In studies of dogs at high risk for heart disease, cTnI has proven to be a valuable tool for detecting myocardial damage and predicting outcomes for diseases such as myxomatous mitral valve disease, DCM and a variety of other acquired and congenital heart diseases (33–35). This evidence concerns the gene TNNI3 and heart disorder.